| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 941 | 2018 |
| Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease M Ioannou, T Alissafi, I Lazaridis, G Deraos, J Matsoukas, A Gravanis, ... The Journal of Immunology 188 (3), 1136-1146, 2012 | 263 | 2012 |
| Linking pesticide exposure and dementia: what is the evidence? I Zaganas, S Kapetanaki, V Mastorodemos, K Kanavouras, C Colosio, ... Toxicology 307, 3-11, 2013 | 184 | 2013 |
| Rising incidence of multiple sclerosis in females associated with urbanization D Kotzamani, T Panou, V Mastorodemos, M Tzagournissakis, ... Neurology 78 (22), 1728-1735, 2012 | 143 | 2012 |
| Molecular basis of human glutamate dehydrogenase regulation under changing energy demands V Mastorodemos, I Zaganas, C Spanaki, M Bessa, A Plaitakis Journal of neuroscience research 79 (1‐2), 65-73, 2005 | 84 | 2005 |
| Long COVID or post COVID-19 syndrome J Lechner-Scott, M Levy, C Hawkes, A Yeh, G Giovannoni Multiple sclerosis and related disorders 55, 103268, 2021 | 83 | 2021 |
| Study of structure–function relationships in human glutamate dehydrogenases reveals novel molecular mechanisms for the regulation of the nerve tissue-specific (GLUD2) isoenzyme A Plaitakis, C Spanaki, V Mastorodemos, I Zaganas Neurochemistry international 43 (4-5), 401-410, 2003 | 72 | 2003 |
| Human GLUD1 and GLUD2 glutamate dehydrogenase localize to mitochondria and endoplasmic reticulum V Mastorodemos, D Kotzamani, I Zaganas, G Arianoglou, H Latsoudis, ... Biochemistry and cell biology 87 (3), 505-516, 2009 | 66 | 2009 |
| Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset A Plaitakis, H Latsoudis, K Kanavouras, B Ritz, JM Bronstein, I Skoula, ... European journal of human genetics 18 (3), 336-341, 2010 | 60 | 2010 |
| Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis HA Papadaki, M Tsagournisakis, V Mastorodemos, C Pontikoglou, ... Bone marrow transplantation 36 (12), 1053-1063, 2005 | 59 | 2005 |
| White matter and deep gray matter hemodynamic changes in multiple sclerosis patients with clinically isolated syndrome EZ Papadaki, VC Mastorodemos, EZ Amanakis, KC Tsekouras, ... Magnetic resonance in medicine 68 (6), 1932-1942, 2012 | 54 | 2012 |
| A case report of motor neuron disease in a patient showing significant level of DDTs, HCHs and organophosphate metabolites in hair as well as levels of hexane and toluene in blood K Kanavouras, MN Tzatzarakis, V Mastorodemos, A Plaitakis, ... Toxicology and applied pharmacology 256 (3), 399-404, 2011 | 53 | 2011 |
| Cell-based modulation of autoimmune responses in multiple sclerosis and experimental autoimmmune encephalomyelitis: therapeutic implications V Mastorodemos, M Ioannou, P Verginis Neuroimmunomodulation 22 (3), 181-195, 2015 | 52 | 2015 |
| Properties and molecular evolution of human GLUD2 (neural and testicular tissue‐specific) glutamate dehydrogenase K Kanavouras, V Mastorodemos, N Borompokas, C Spanaki, A Plaitakis Journal of neuroscience research 85 (15), 3398-3406, 2007 | 49 | 2007 |
| Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history A Fanouriakis, V Mastorodemos, C Pamfil, E Papadaki, P Sidiropoulos, ... Seminars in arthritis and rheumatism 43 (6), 751-758, 2014 | 39 | 2014 |
| Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome T Panou, V Mastorodemos, E Papadaki, PG Simos, A Plaitakis Behavioural neurology 25 (4), 311-326, 2012 | 36 | 2012 |
| The human GLUD2 glutamate dehydrogenase: localization and functional aspects I Zaganas, K Kanavouras, V Mastorodemos, H Latsoudis, C Spanaki, ... Neurochemistry international 55 (1-3), 52-63, 2009 | 36 | 2009 |
| Medical treatment with thiamine, coenzyme Q, vitamins E and C, and carnitine improved obstructive sleep apnea in an adult case of Leigh disease C Mermigkis, I Bouloukaki, V Mastorodemos, A Plaitakis, V Alogdianakis, ... Sleep and Breathing 17 (4), 1129-1135, 2013 | 33 | 2013 |
| Estrogen modification of human glutamate dehydrogenases is linked to enzyme activation state N Borompokas, MM Papachatzaki, K Kanavouras, V Mastorodemos, ... Journal of biological chemistry 285 (41), 31380-31387, 2010 | 31 | 2010 |
| Regional MRI perfusion measures predict motor/executive function in patients with clinically isolated syndrome EZ Papadaki, PG Simos, VC Mastorodemos, T Panou, TG Maris, ... Behavioural neurology 2014, 2014 | 20 | 2014 |
